Invesco’s ProKidney PROK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$83.1K Buy
+40,719
New +$74.5K ﹤0.01% 3759
2025
Q2
Sell
-32,258
Closed -$28.3K 3843
2025
Q1
$28.3K Buy
32,258
+135
+0.4% +$187 ﹤0.01% 3732
2024
Q4
$54.3K Buy
32,123
+1,643
+5% +$2.96K ﹤0.01% 3685
2024
Q3
$58.5K Buy
30,480
+2,617
+9% +$5.94K ﹤0.01% 3670
2024
Q2
$68.5K Sell
27,863
-240
-0.9% -$644 ﹤0.01% 3792
2024
Q1
$46.1K Sell
28,103
-833
-3% -$1.22K ﹤0.01% 3810
2023
Q4
$51.5K Sell
28,936
-11,710
-29% -$25.1K ﹤0.01% 3748
2023
Q3
$186K Buy
40,646
+14,578
+56% +$140K ﹤0.01% 3613
2023
Q2
$292K Buy
+26,068
New +$277K ﹤0.01% 3506

Other funds holding PROK

Invesco's PROK Position: Q2 2026 in Review

Invesco opened a new position in ProKidney (PROK) in Q2 2026: 40,719 shares worth $83.1K. The stake represents ﹤0.01% of the portfolio and ranks #3759 among its holdings. This is a return to the name: Invesco previously reported a position in PROK as recently as Q1 2025.

Invesco first reported a position in PROK in Q2 2023 and has held it in 9 quarters since. The position peaked at $292K in Q2 2023. 71 funds tracked by Wall St. Rank hold PROK as of Q2 2026.

  • Invesco held 40,719 shares of ProKidney worth $83.1K as of Q2 2026.
  • ProKidney was a new Invesco position in Q2 2026.
  • ProKidney made up ﹤0.01% of Invesco's portfolio in Q2 2026, its #3759 holding.
  • Invesco first reported a position in ProKidney in Q2 2023 and has held it in 9 quarters since.
  • Invesco's ProKidney position peaked at $292K in Q2 2023.
  • 71 funds tracked by Wall St. Rank held ProKidney as of Q2 2026.

Based on Invesco's 13F filing for Q2 2026, filed 14 Aug 2026.